The narrow FDA labeling makes it so that only a minority of men who could benefit from treatment are considered ‘on-label’ ...

The drugs have soared in popularity, with some men taking them for unapproved uses like anti-aging or increasing muscle mass.

Sara Moniuszko is a health and lifestyle reporter at CBSNews.com. Previously, she wrote for USA Today, where she was selected to help launch the newspaper's wellness vertical. She now covers breaking ...

Here’s what science actually shows about declining testosterone in young adults, and why treatment is rarely the first answer ...

In 2018 with Xyosted, Antares brought to the market a user-friendly testosterone replacement therapy for hypogonadism, with the drug administered at home by weekly injection. Less than four years ...

Testosterone replacement therapy used to treat "low T" doesn't appear to increase the risk for serious heart problems as some experts had feared, according to research published Friday in The New ...